OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Archive for janvier, 2025

OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing

OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing

The Pre-Commercial Procurement (PCP) project OncNGS has entered its final phase with two cutting-edge solutions for Next-Generation Sequencing (NGS) cancer tests. The Call-off for Phase[…]
Read More

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer